Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Injectable platelet-rich fibrin versus corticosteroid for partial supraspinatus shoulder injuries
RBR-7jw7z2gPhase 2Not yet recruiting
- Sponsor
- Federal University of São Paulo
- Start
- Mar 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of triamcinolone and platelet rich fibrin in shoulder tendinopathy and partial thickness supraspinatus tendon tear (2 arms), sponsored by Federal University of São Paulo. Planned start Mar 2025; status: not yet recruiting.
02
Drugs
triamcinoloneplatelet rich fibrin
03
Conditions
shoulder tendinopathypartial thickness supraspinatus tendon tear
Beyond the preview
Go deeper on RBR-7jw7z2g.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-7jw7z2g.